BANDINI, GIUSEPPE
BANDINI, GIUSEPPE
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice
2017 Giannaccare, G; Bonifazi, F; Sessa, M; Dan, E; Arpinati, M; Fresina, M; Bandini, G; Cavo, M; Versura, P; Campos, E C
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation
2016 Giannaccare, Giuseppe; Bonifazi, Francesca; Sessa, Mariarosaria; Fresina, Michela; Arpinati, Mario; Bandini, Giuseppe; Versura, Piera
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients
2016 Curti, Antonio; Ruggeri, Loredana; Parisi, Sarah; Bontadini, Andrea; Dan, Elisa; Motta, MARIA ROSA; Rizzi, Simonetta; Trabanelli, Sara; Ocadlikova, Darina; Lecciso, MARIANGELA STEFANIA; Giudice, Valeria; Fruet, Fiorenza; Urbani, Elena; Papayannidis, Cristina; Martinelli, Giovanni; Bandini, Giuseppe; Bonifazi, Francesca; Lewis, RUSSEL EDWARD; Cavo, Michele; Velardi, Andrea; M. Lemoli, Roberto
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells
2014 Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Maria Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
2013 Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL
PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT).
2013 Versura P; Giannaccare G; Bonifazi F; Bandini G; Ridolfi L.
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells
2013 Gianluca Storci;Sara Bertoni;Sabrina De Carolis;Alessio Papi;Marina Nati;Claudio Ceccarelli;Chiara Pirazzini;Paolo Garagnani;Alberto Ferrarini;Genny Buson;Massimo Delledonne;Michelangelo Fiorentino;Elisa Capizzi;Elisa Gruppioni;Mario Taffurelli;Donatella Santini;Claudio Franceschi;Giuseppe Bandini;Francesca Bonifazi;Massimiliano Bonafé
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients.
2012 Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati M; Bandini G.
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis
2012 F. Bonifazi; G. Bandini; M. Arpinati; G. Tolomelli; M. Stanzani; M. R. Motta; S. Rizzi; V. Giudice; E. Dan; E. Massari; P. Tazzari; A. Bontadini; P. Pagliaro; M. Baccarani
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
2012 Mauro F.R.; Bandini G.; Barosi G.; Billio A.; Brugiatelli M.; Cuneo A.; Lauria F.; Liso V.; Marchetti M.; Meloni G.; Montillo M.; Zinzani P.L.; Tura S.
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
2011 Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Urbani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M.
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
2007 Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Borrelli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M.
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT).
2007 Arpinati M.; Versura P.; Profazio V.; Giannini M.B.; Bonifazi F.; Bandini G.; Stanzani M.; Giovannini M.; Campos E.C.; Baccarani M.
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
2007 Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Rondelli D.
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
2007 Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin R; Martinelli G; Baccarani M.
Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation.
2006 Patriarca F; Skert C; Bonifazi F; Sperotto A; Fili C; Stanzani M; Zaja F;Cerno M; Geromin A; Bandini G; Baccarani M; Fanin R.
GVHD and prognostic factors.
2006 Bonifazi F; Bandini G; Giovannini M; Falcioni S; Baccarani M.
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B
2006 M. Stanzani; N. Vianelli; G. Bandini; S. Paolini; M. Arpinati; F. Bonifazi; B. Giannini; C. Agostinelli; M. Baccarani; P. Ricci.
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia.
2005 PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M.
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
2005 BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice | Giannaccare, G; Bonifazi, F; Sessa, M; Dan, E; Arpinati, M; Fresina, M; Bandini, G; Cavo, M; Vers...ura, P; Campos, E C | 2017-01-01 | EYE | - | 1.01 Articolo in rivista | - |
| Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation | Giannaccare, Giuseppe; Bonifazi, Francesca; Sessa, Mariarosaria; Fresina, Michela; Arpinati, Mari...o; Bandini, Giuseppe; Versura, Piera | 2016-01-01 | CORNEA | - | 1.01 Articolo in rivista | - |
| Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients | Curti, Antonio; Ruggeri, Loredana; Parisi, Sarah; Bontadini, Andrea; Dan, Elisa; Motta, MARIA ROS...A; Rizzi, Simonetta; Trabanelli, Sara; Ocadlikova, Darina; Lecciso, MARIANGELA STEFANIA; Giudice, Valeria; Fruet, Fiorenza; Urbani, Elena; Papayannidis, Cristina; Martinelli, Giovanni; Bandini, Giuseppe; Bonifazi, Francesca; Lewis, RUSSEL EDWARD; Cavo, Michele; Velardi, Andrea; M. Lemoli, Roberto | 2016-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells | Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Mari...a Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli | 2014-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). | Versura P; Giannaccare G; Bonifazi F; Bandini G; Ridolfi L. | 2013-01-01 | - | Tear Film Ocular Surface Society | 4.01 Contributo in Atti di convegno | - |
| Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells | Gianluca Storci;Sara Bertoni;Sabrina De Carolis;Alessio Papi;Marina Nati;Claudio Ceccarelli;Chiar...a Pirazzini;Paolo Garagnani;Alberto Ferrarini;Genny Buson;Massimo Delledonne;Michelangelo Fiorentino;Elisa Capizzi;Elisa Gruppioni;Mario Taffurelli;Donatella Santini;Claudio Franceschi;Giuseppe Bandini;Francesca Bonifazi;Massimiliano Bonafé | 2013-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. | Zinzani PL; Bonifazi F; Pellegrini C; Casadei B; Argnani L; Motta MR; Dan E; Stanzani M; Arpinati... M; Bandini G. | 2012-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis | F. Bonifazi; G. Bandini; M. Arpinati; G. Tolomelli; M. Stanzani; M. R. Motta; S. Rizzi; V. Giudic...e; E. Dan; E. Massari; P. Tazzari; A. Bontadini; P. Pagliaro; M. Baccarani | 2012-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia. | Mauro F.R.; Bandini G.; Barosi G.; Billio A.; Brugiatelli M.; Cuneo A.; Lauria F.; Liso V.; March...etti M.; Meloni G.; Montillo M.; Zinzani P.L.; Tura S. | 2012-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. | Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Ur...bani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M. | 2011-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. |
Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Bor...relli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M. |
2007-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). | Arpinati M.; Versura P.; Profazio V.; Giannini M.B.; Bonifazi F.; Bandini G.; Stanzani M.; Giovan...nini M.; Campos E.C.; Baccarani M. | 2007-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. | Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Ronde...lli D. | 2007-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis. | Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin ...R; Martinelli G; Baccarani M. | 2007-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation. | Patriarca F; Skert C; Bonifazi F; Sperotto A; Fili C; Stanzani M; Zaja F;Cerno M; Geromin A; Band...ini G; Baccarani M; Fanin R. | 2006-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| GVHD and prognostic factors. | Bonifazi F; Bandini G; Giovannini M; Falcioni S; Baccarani M. | 2006-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B | M. Stanzani; N. Vianelli; G. Bandini; S. Paolini; M. Arpinati; F. Bonifazi; B. Giannini; C. Agost...inelli; M. Baccarani; P. Ricci. | 2006-01-01 | JOURNAL OF INFECTION | - | 1.01 Articolo in rivista | - |
| Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. | PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M. | 2005-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. | BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M. | 2005-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |